Treanda bendamustine: Phase Ib/II started

The Multiple Myeloma Research Consortium (MMRC) began an open-label, U.S. Phase Ib/II trial to evaluate Treanda plus Revlimid lenalidomide and dexamethasone in about 80 patients with relapsed MM. Ast...